Hemagglutinin (HA)-specific antibodies directly bind the virus and prevent its entry into host cells, providing narrow immunity from reinfection by closely related strains. CD8 T cell responses to IAV generated against highly conserved viral proteins/epitopes contribute to clearance of virus during primary IAV infection and also confer broad heterosubtypic protection in animal models. Recent evidence links the cross-reactive CD8 T cell response in man to reduced viral replication and protection from severe illness in pandemic H1N1 infections in European populations, and H7N9 infections in China. Because pre-existing T-cell immunity, independent of baseline antibodies, protects against symptoms and viral shedding associated with influenza, influenza vaccines that stimulate broadly reactive CD8 T cell responses may have the capacity to protect against any pandemic influenza A virus. Human infections with H5N1 and H7N9 avian IAV and the 2009 H1N1 pandemic have spurred an interest in the development of vaccines against IAV with pandemic potential. Major challenges to this effort include our inability to predict which virus will emerge and rapid production and deployment of vaccine if the virus spreads rapidly and vaccine yield is not optimal. In addition, the number of doses of vaccine required depends on whether the population is immunologically naive. Therefore, vaccine technologies that elicit broadly cross-reactive and protective immune responses against a range of influenza viruses and that can be scaled-up are desirable. We compared the efficacy of two intranasally delivered non-replicating vaccines (H1 and H5 S-FLU) that are based on the suppression of the hemagglutinin signal sequence, with the corresponding H1N1 and H5N1 cold-adapted (ca) live attenuated influenza vaccines in mice and ferrets. Administration of two doses of H1 or H5 S-FLU vaccines protected mice and ferrets from lethal challenge with homologous, heterologous and heterosubtypic influenza viruses and two doses of S-FLU and ca vaccines were comparable. Importantly, when ferrets vaccinated with one dose of H1 S-FLU or ca vaccine were challenged with the homologous H1N1 virus, the challenge virus failed to transmit to naive ferrets by the airborne route. S-FLU technology can be rapidly applied to any emerging influenza virus and the promising preclinical data support further evaluation in humans.

Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
Zip Code
Paules, Catharine I; Lakdawala, Seema; McAuliffe, Josephine M et al. (2017) The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses. J Infect Dis 216:356-365
Boonnak, Kobporn; Matsuoka, Yumiko; Wang, Weijia et al. (2017) Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses. J Virol 91:
Kuah, Li-Fang; Tang, Lay-Hoon; Sutton, Troy et al. (2017) Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice. J Gen Virol 98:155-165
Sutton, Troy C; Lamirande, Elaine W; Czako, Rita et al. (2017) Evaluation of the biological properties and cross-reactive antibody response to H10 influenza viruses in ferrets. J Virol :
Broadbent, Andrew J; Santos, Celia P; Paskel, Myeisha et al. (2015) Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates. Vaccine 33:193-200
Baz, Mariana; Boonnak, Kobporn; Paskel, Myeisha et al. (2015) Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge. MBio 6:e01487-15
Xiong, Xiaoli; Corti, Davide; Liu, Junfeng et al. (2015) Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody. Proc Natl Acad Sci U S A 112:9430-5
Baz, Mariana; Paskel, Myeisha; Matsuoka, Yumiko et al. (2015) A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. J Virol 89:1652-9
Czako, Rita; Subbarao, Kanta (2015) Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virol 10:1033-1047
Baz, Mariana; Paskel, Myeisha; Matsuoka, Yumiko et al. (2015) A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets. J Virol 89:6907-17

Showing the most recent 10 out of 48 publications